<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>Threonine is_biomarker_for Disease progression in lung cancer — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>Threonine</strong>
  <span class="pred">&mdash;is_biomarker_for&rarr;</span>
  <strong>Disease progression in lung cancer</strong>
</div>
<div class="entity-id">HMDB:HMDB0000167 &nbsp;&middot;&nbsp; MESH:D008175</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:100%;--color:#2ca02c"></div>
<div class="stat-row">
  <span>Class: Physical (10.0)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 132.00<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; Curated 0.5 &middot; AI 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts 0.8). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#2ca02c" title="Physical"></span><span>Physical</span><a href="https://doi.org/10.1007/s11306-016-0961-5">10.1007/s11306-016-0961-5</a> <a href="https://www.ebi.ac.uk/metabolights/MTBLS200">MTBLS200</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 11 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:100px"></span><span>11</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">cholesterol — is_biomarker_for → lung cancer</span><a href="../claim/e40c936f2f599b8f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">oleic acid — is_biomarker_for → lung cancer</span><a href="../claim/c0e12d2bcb626ea2.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">myo-inositol — is_biomarker_for → lung cancer</span><a href="../claim/c42adec09cd22c9c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">2-hydroxybutyric acid — is_biomarker_for → lung cancer</span><a href="../claim/cae262d04063111c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">4-hydroxybutyric acid — is_biomarker_for → lung cancer</span><a href="../claim/ec4e2f7ee7da2105.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">5-metabolite panel (cholesterol, oleic acid, myo-inositol, 2-hydroxybutyric acid, 4-hydroxybutyric acid) — distinguishes → lung cancer vs healthy control</span><a href="../claim/6f9477c57f95aab9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">cholesterol — correlates_with → lung cancer proliferation via Ca2+ signaling pathway</span><a href="../claim/1f72d22fd0604c7e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">oleic acid — correlates_with → lung cancer proliferation via Ca2+ signaling pathway</span><a href="../claim/e09cf230f9a2c383.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">myo-inositol — correlates_with → lung cancer proliferation via Ca2+ signaling pathway</span><a href="../claim/80586499a4eb787c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">2-hydroxybutyric acid — correlates_with → lung cancer proliferation via Ca2+ signaling pathway</span><a href="../claim/5bf9aaadf0e07e4f.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#2ca02c"></span><span class="cite-claim-triple">4-hydroxybutyric acid — correlates_with → lung cancer proliferation via Ca2+ signaling pathway</span><a href="../claim/7b724e7c8fd15425.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>3b0afa3f040b8177</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/HMDB:HMDB0000167">HMDB:HMDB0000167</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D008175">MESH:D008175</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
